BMRN vs PSX · P/E 40, rev $1.76B vs P/E 17, rev $83.54B
Biomarin Pharmaceutical Inc (BMRN) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported PSX revenue for 2026-06-30 was $83.54B. Net income was $4.05B. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the BMRN and PSX stock pages for the full models.
Not investment advice.